Table 5.
Subjects | Trials | LR (ms) | MSt (ms) | TSt (ms) | PSw (ms) | Sw (ms) |
---|---|---|---|---|---|---|
Subject A | Trial 1 | −32 | 134 | 9 | −85 | −14 |
Trial 2 | −5 | 121 | 14 | −94 | −1 | |
Trial 3 | −47 | 139 | 2 | −75 | 6 | |
| ||||||
Subject B | Trial 1 | 18 | 17 | 21 | −64 | −30 |
Trial 2 | 43 | 42 | 26 | −40 | −41 | |
Trial 3 | 48 | 29 | 17 | −40 | −38 | |
| ||||||
Subject C | Trial 1 | −30 | 97 | 15 | −65 | 11 |
Trial 2 | −26 | 102 | 18 | −51 | 8 | |
Trial 3 | −23 | 104 | 7 | −56 | 10 | |
| ||||||
Subject D | Trial 1 | 48 | 38 | 27 | −43 | −39 |
Trial 2 | 22 | 21 | 22 | −60 | −27 | |
Trial 3 | 43 | 34 | 18 | −39 | −39 | |
| ||||||
Subject E | Trial 1 | −25 | 91 | 18 | −61 | 13 |
Trial 2 | −25 | 98 | 13 | −55 | 12 | |
Trial 3 | −22 | 100 | 19 | −47 | 12 | |
| ||||||
Avg (±SD) | −1 (±33) | 78 (±41) | 16 (±7) | −58 (±16) | −10 (±22) |